$2,963.40 travel Payment -- Bayer Healthcare to Dr. Mark Perez

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Bayer Healthcare made a $3.0K travel payment to Mark Perez, a Ophthalmology specialist in City, AZ. The payment was associated with Revlimid. The payment of $2963.40 to Dr. Mark Perez was for travel and lodging expenses related to Revlimid. This payment was made by Bayer Healthcare on May 25, 2024. The payment was categorized as 'travel' and specifically for 'Travel and Lodging'.

Patient Guidance: What This Payment Means for You

This payment covers travel and lodging expenses, which may be related to educational events or research involving Revlimid. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Travel and lodging payments are common in the pharmaceutical industry, particularly for educational events or consultations related to specific drugs like Revlimid.

Regulatory Context: Sunshine Act Requirements

Payments for travel and lodging must be reported under the Open Payments program if they are made by applicable manufacturers to physicians or teaching hospitals.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• physician-payments
• travel-expenses
• bayer-healthcare
• revlimid
• ophthalmology

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $3.0K payment for?

This was a travel payment of $3.0K from Bayer Healthcare to Mark Perez, categorized as "Travel and Lodging". It was associated with Revlimid. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Mark Perez accept pharmaceutical money?

Yes, Mark Perez received this $3.0K payment from Bayer Healthcare. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Mark Perez's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $3.0K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Ophthalmology?

To compare this payment against Ophthalmology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Ophthalmology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Mark Perez's relationship with Bayer Healthcare?

The payment amount is $2963.40. This $3.0K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Ophthalmology?

The payment type is 'travel'.

What should patients do after learning about this payment?

This payment covers travel and lodging expenses, which may be related to educational events or research involving Revlimid.

What else should I know about this travel payment?

The payment nature is 'Travel and Lodging'.

Related Reports

• View Dr. Mark Perez's full payment report
• Bayer Healthcare full spending report
• Browse all Ophthalmology payments
• Browse all payments in Arizona
• Search for other payments